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ABSTRACT Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged
by the World Health Organization End TB Strategy need to innovate, with approaches such as digital
health (electronic and mobile health) in support of patient care, surveillance, programme management,
training and communication. Alongside the large-scale roll-out required for such interventions to make a
significant impact, products must stay abreast of advancing technology over time. The integration of
artificial intelligence into new software promises to make processes more effective and efficient, endowing
them with a potential hitherto unimaginable. Users can benefit from artificial intelligence-enabled pattern
recognition software for tasks ranging from reading radiographs to adverse event monitoring, sifting
through vast datasets to personalise a patient’s care plan or to customise training materials. Many experts
forecast the imminent transformation of the delivery of healthcare services. We discuss how artificial
intelligence and machine learning could revolutionise the management of TB.
@ERSpublications
Tuberculosis control, and the where and why of artificial intelligence http://ow.ly/GwuY30bCXkJ
Cite this article as: Doshi R, Falzon D, Thomas BV, et al. Tuberculosis control, and the where and
why of artificial intelligence. ERJ Open Res 2017; 3: 00056-2017 [https://doi.org/10.1183/
23120541.00056-2017].
The content of this work is © the authors or their employers. Design and branding are © ERS 2017. This article is open
access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Received: April 24 2017 | Accepted: April 30 2017
Conflict of interest: None declared.
https://doi.org/10.1183/23120541.00056-2017 ERJ Open Res 2017; 3: 00056-2017
REVIEW
TUBERCULOSIS
Introduction
The World Health Organization (WHO) estimates that there were 10.4 million new cases of tuberculosis
(TB) and 1.8 million deaths caused by TB in 2015, a poignant reminder of the threat that this epidemic
continues to pose to global health despite concerted efforts to curb it in recent decades [1]. The WHO’s
End TB strategy maps out the global response required between 2016 and 2035 in order to reduce
worldwide TB incidence by 90% and TB mortality by 95% [2]. Digital technologies can make global
efforts to end TB more effective and efficient [3]. Access to the internet and affordable mobile devices is
becoming increasingly widespread in low- and middle-income countries. In the past 2 years, WHO and its
partners identified a set of priority electronic and mobile health products and concepts which were
advantageously positioned to have a high impact on different domains of TB care and prevention [4].
Target product profiles (TPPs), consisting of descriptions of how these tools should work, were developed
in order to communicate the product attributes to all partners involved in advancing them. The TPPs are
intended to be dynamic documents which are updated regularly to incorporate the latest in the technology
and remain relevant to TB practitioners and patients who should benefit from the finished product.
Digital technologies can support efforts against TB in four ways: patient care, surveillance, programme
management and e-learning [3]. A number of currently available digital products already address one or
more of these functions, but to achieve the ambitious goals of the End TB strategy these tools need to be
rolled out more extensively. Moreover, their performance needs to be augmented by incorporating
innovations such as artificial intelligence (the branch of computer science concerned with the automation
of intelligent behaviour [5]) and machine learning (the subfield of computer science that gives computers
the ability to learn without being explicitly programmed [6]) into the future successors of today’s
technology [7]. Artificial intelligence is already embedded in common applications that recognise voice
and visual patterns, such as speech transcription software and computer-aided diagnostic platforms.
In this article, we present some leading digital technologies being applied in TB control and discuss the
value that artificial intelligence could add to the next generation of technology.
Patient care
Adherence to medication is one of the most important challenges facing TB patients. The need to travel
regularly to health facilities over many months for treatment observation influences compliance to
treatment for chronic conditions such as TB [8]. Long-term adherence can be motivated through
patient–provider communication, which can be improved using informatics. Several promising digital
technologies are now being introduced for this purpose. Electronic medication monitors capable of
transmitting short message service (texts) have been successfully deployed in low-resource settings with a
high TB burden [9]. In addition, virtual directly observed treatment via video (VOT or VDOT), which
involves the provider observing a TB patient taking medication via video sent over a smartphone or tablet
computer has been shown to be feasible under socially challenging conditions, as access to affordable
devices and to broadband internet extends to most places where TB patients live [10–12]. Both of these
technologies still require substantial input from health workers to interpret the signals they send.
Moreover, the risk of breach of privacy, such as that associated with the transmission of video over
internet, has been a concern. These risks could be reduced through encryption. However, smarter methods
are being employed. The potential of artificial intelligence to recognise patterns and gestures reliably and
consistently could add huge value to the toolset currently available to the practitioners [13]. For instance,
in VDOT, software could be enabled to identify the unique features of a particular person taking a specific
medication; when combined with the timestamp of the event and the mobile phone number, a distinct
signature can be generated and transmitted as a small data packet to the caregiver. Beyond TB, this
technique could be of value in other situations requiring close clinical monitoring.
While treatment adherence has attracted much focus, digital technology could improve TB patient care
through other approaches. For instance, “clip-on” hardware can convert a smartphone into a clinical
instrument [14, 15]. Cognitive computing (systems that learn at scale, reason with purpose and interact
with humans naturally [16]) could power algorithms within clinical decision support systems to help
clinicians with diagnostic and treatment decisions [17]. They could help, for instance, in the causality
assessment of adverse events through the recognition of patterns and the association of various data.
Artificial intelligence could enable rapid access to previously unreachable masses of data. These could
include diverse sources ranging from cloud-based datasets that are not usually roped into clinical
decision-making, as well as rich knowledge bases which usually remain locked up inside the individual
patient’s genome [18]. Access to this information helps both the human operator and the machine to
learn. If an advanced artificial intelligence application can be incorporated into a mobile-based clinical
decision support application, TB workers worldwide would not only benefit from its use, but also enrich it
by the data and feedback they supply. Such a personalised approach to care is bound to challenge
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time-honoured practices, such as how new treatment regimens have been traditionally introduced in
clinical care on the basis of observations extrapolated from drug trial participants. The demand for these
resource-intensive studies, which can take several years to complete, could thus decrease.
Surveillance
Attempts to record and track TB patient information electronically have a long history, and recent years
have seen a global expansion and diversification of software being deployed for this purpose, often in
open-source format [19–21]. Another critical milestone has been internet penetration. Technology
acceptance over time has been impressive. For instance, in the early 1990s, TB officers in southern India
started to email their TB surveillance reports to the higher administrative level. In later years, public health
facilities experimented with different electronic medical records systems. More recently, and in support of
the notification of TB by public and private practitioners, which became mandatory in 2012, a nationwide,
online, disaggregated TB reporting platform (NIKSHAY) was implemented with the immediate result of
facilitating the increasing reporting of cases [22, 23]. In China, the TB information management system
provides another example of the large-scale use of digital technology for TB surveillance [20]. The system
has evolved over time and offers a number of benefits, such as the flagging of “at-risk” TB patients for the
evaluation of drug resistance and the direct reporting to the national infectious disease register to ensure
timeliness and accuracy and to limit duplication of work.
Artificial intelligence could add value to the review of disaggregated patient records. Where unique
personal identifiers are commonly unavailable an intelligent system could still trace an individual person’s
“signature” over time within large datasets. This would be greatly important in TB surveillance, for
instance to trace people with clinical manifestations suggestive of TB or disease relapse or adverse drug
reactions and to complete the monitoring of mortality and the linkage with HIV. In addition, this
approach could identify predictors of treatment failure, which in turn could be useful in patient care as
well as TB drug development [24, 25]. Artificial intelligence has been proposed as a means to detect
outbreaks of TB early on [26].
Programme management
Information has always been central to planning and management. In TB programmes the handling of
diagnostic data is crucial to maximise coverage of services, identify inequities and malfunctions and limit
waste. “Connected diagnostics” is becoming a flagship concept in TB programme management, helping to
monitor diagnostic machines remotely and to consolidate the results data. Successful implementation of
such systems in low-resource settings has been given a boost by the advent of molecular diagnostics that
generate their results digitally [27]. The next generation of products could go a step further by helping to
interpret results data and match them with those from other diagnostic processes. Artificial neural
networks have been applied to clinical situations that still pose a problem for practitioners, such as
microscopy sputum smear-negative TB and pleural TB, in settings where diagnostic options are limited
[28, 29]. The potential contribution of computerisation to radiology, another important field in TB
diagnostics was first recognised decades ago [30]. Nonetheless, the automated detection of TB on digital
chest radiographs has yet to become more clinically relevant [31].
e-Learning
e-Learning uses electronic media and devices for training and communication [32]. In its different forms,
ranging from digital texts that replace paper to advanced online interaction, e-learning is rewriting the
textbook approach to human resource development and patient education. “Gamification” and augmented
reality environments are among the novel techniques being tested to simulate problem-solving
environments for the learner [33]. Artificial intelligence is being used to emulate the human tutor’s ability
both to customise the method of knowledge acquisition, as well as to prioritise content based on the
learner’s capacity, preference and knowledge gaps. Developing e-learning materials requires a
multidisciplinary mix of skills to ensure that the content is not only pertinent, correct and up to date, but
also attractive in format and appropriately sized for the media being used to deliver it. It thus incurs a
substantial cost. Artificial intelligence can automate the laborious classification of texts and images needed
to create the content of an app, thus speeding up the process and lowering costs. Moreover, artificial
intelligence could empower the automated grading of student assessments, increasing the value of online
courses and releasing time for tutors to devote to other tasks.
The (near) future?
The huge capacity of digital tools to compute and store data has profound implications in the healthcare
sector, where massive amounts of data are generated and the prospect of sifting them efficiently to
improve patient outcomes is particularly appealing. Many of the healthcare processes streamlined by
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digital technologies still require supervision by the human expert, albeit to varying degrees. Classical
examples are online discussion groups dedicated to clinical problems such as drug-resistant TB, which are
moderated by human expertise [34–36]. While robots have grown to outperform their teachers in certain
tasks, they have not yet supplanted medical specialists. This is the next frontier, which is set to be
breached as machines progress from supportive tools to take a bigger share of the driving seat in medical
decision-making. It appears that the role of the healthcare worker is destined to become primarily that of
the “gatekeeper” of clinically relevant data. Medical specialties that are commonly solicited in pulmonology
and TB, such as imaging, microscopy and pathology depend heavily upon the interpretation of disease
morphology and may thus be among the ones most “disrupted” by automated pattern recognition. In
addition, artificial intelligence can contribute to basic research.
While artificial intelligence has been incorporated in medical innovations since the 1970s [37],
forthcoming advances such as cognitive computational systems will mark a radical departure from the
previous order. Telemedicine and remote consultations can deliver healthcare via a home computer or
mobile device, challenging the conventions of patient–carer relationships. Portable and wearable devices
equipped with artificial intelligence-enhanced software can monitor patients and issue alerts fatigue-free to
a degree which would be impossible even where trained workers are available. These developments will
strengthen the trend towards home-based care and reduce demand on “brick and mortar” healthcare
facilities. The arrival of the smartphone in the past decade has given us a taste of how technology can
rapidly transform lay persons into informed clients of healthcare services. This trend will keep expanding
in future and will equip patients and their caregivers with more options to interact and to make the best
possible clinical decisions.
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